Investor Relations
Sign up for our newsletter to get the latest investor updates
November 24, 2023
Goldman Small Cap Research Coverage Initiation
Our Pick of the Year; Major Catalysts and Valuation Drivers Ahead and a $4.60 Price Target
April 28, 2025
Singular Research Coverage Initiation
Launch of unbuzzdTM a Significant Milestone, Firm Name Changed to Quantum BioPharma; Maintain Buy Venture.
Latest Releases
Investor Relations
Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
QNTM@mzgroup.us
For any investors outside of the U.S.A and Canada, you can trade on the Upstream Exchange.
Stock Quote
Company Structure
Our leadership consists of a passionate management team with diverse industry knowledge, committed to science, therapeutic drug discovery and development.
Board Advisors
As an original “shark” on the hit TV show Shark Tank, the creator of the infomercial, pioneer of the As Seen on TV brand, and co-founding board member of the Entrepreneur’s Organization, Kevin Harrington has pushed past all the questions and excuses to repeatedly enjoy 100X success.
His legendary work behind the scenes of business ventures has produced more than $5 billion in global sales, the launch of more than 500 products, and the making of dozens of millionaires. He’s launched massively successful products like The Food Saver, Ginsu Knives, The Great Wok of China, The Flying Lure, and many more. He has worked with amazing celebrities turned entrepreneurs including, like Billie Mays, Tony Little, Jack LaLanne, and George Foreman to name a few. Kevin’s been called the Entrepreneur’s Entrepreneur and the Entrepreneur Answer Man, because he knows the challenges unique to start-ups and has a special passion for helping entrepreneurs succeed.
Gerry David is a solutions-focused Entrepreneur, Leader, and Board Member with more than 40 years of success across the consumer products, manufacturing, and high-tech industries. Leveraging extensive experience leading five comprehensive turnarounds of both public and private companies with global scopes spanning 72 countries.
He is a valuable asset for startup or established companies looking to drive long-term, sustainable growth. His broad areas of expertise include sales and marketing, operations management, financial analysis, capital raising, supply chain management, M&A, regulatory and strategic planning. In recognition of his professional achievements, he was one of only 25 Gold Winners in the prestigious 2016 CEO World Awards and was selected as “The Leader” in the CEO of the Year category.
Throughout his executive career, Gerry has held leadership positions at organizations including Celsius Holdings, Vitarich Labs, Home Shopping Network Direct and his consulting firm Gerry David & Associates LLC, where he currently serves as CEO. He has been responsible for leading the turnaround of Celsius Holdings (CELH: NASDAQ), a beverage company on the verge of going out of business, driving 5 consecutive years of record revenue, increasing shareholder value by 35x, establishing a subsidiary in Hong Kong, launching products in Asia, South America, Europe, and the Middle East, and establishing manufacturing in Germany, China, and the US; Gerry began his career by founding a systems integration company specializing in the hospitality industry, growing the organization to offices in six states prior to its sale to a public entity.
Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021. Mr. Malone focuses deeply on pattern recognition skills and data research to differentiate himself from other financial advisors.
His investment philosophy is based on rigorous research, disciplined risk management, and a long-term approach that seeks to maximize returns while minimizing risk. His Firm identifies undervalued assets and sectors while tactically rebalancing investments to unseen macro conditions.
Kevin has grown his following in communities fighting market corruption in recent years and wants to continue that fight forever. Kevin also started a charitable fund that he plans on using to get personal finance and financial literacy implemented into the US Public Education System. He believes Americans were always at a disadvantage when it comes to finance because they were never taught it. This is unacceptable to him, and he believes everyone should have the right to learn personal finance for free.
Alexander Bar is an Emmy-winning TV producer, screenwriter and children’s author with more than 20 years’ experience in the children’s media business having created and produced many hit preschool TV series including Ricky Zoom, Ranger Rob and Mike the Knight. In 2015, Alexander moved to Toronto from the UK and founded Milkcow Media Inc., an independent media entertainment company specialising in TV and digital content creation for kids and family.
Alexander was diagnosed with multiple sclerosis in 2019 and is firmly committed to raising awareness about the challenges of living with this disease and promoting innovative research programs and treatments, especially those aimed at progressive MS for which there is a great unmet need. Alexander holds a Bachelor of Arts Degree in English and French Law. He’s been a keen amateur body builder all his life and has starred in two major musicals in the West End of London, UK.
Sanjiv Chopra, MD, is Professor of Medicine and served as Faculty Dean for Continuing Medical Education at Harvard Medical School for 12 years. He serves as a Marshall Wolf Distinguished Clinician Educator Brigham and Women’s Hospital.
Dr. Chopra has more than 170 publications and ten books to his credit. Dr. Chopra is Editor-in-Chief of the Hepatology Section of UpToDate, the most widely used electronic textbook in the world subscribed to by more than 1.5 million physicians in 195 countries.
He is a sought after inspirational speaker across the United States and abroad, addressing diverse audiences on topics related to medicine, leadership, happiness, and living with purpose.
Dr. Sanjiv Chopra's recent literary contributions include three impactful books:
"Coffee: The Magical Elixir"
Uncover fascinating facts that will astound and perk you up.
"Conquer Your Diabetes: Prevention. Control. Remission"
Co-authored with Martin Abrahamson, this book delves into comprehensive strategies for managing diabetes.
"Ignite The Fire Within: Master Your Speaking and Writing"
Co-authored with Rick Najera, this book is a guide to mastering the art of speaking and writing, igniting the fire within for effective communication.
Competitive Advantage / Value Proposition
World-Class Pipeline
Neurodegenerative and neuropsychiatric disease, multi-billion dollar markets, unmet need, decades of research de-risk our drugs
Lucid-MS: New Chemical Entity for Multiple Sclerosis, pre-clinical research re-established use of paralyzed rear legs in MS mouse model, research published in peer-reviewed journals. Quantum BioPharma has finished dosing in phase-1 for Lucid-MS (Lucid-21-302) for first in-class human safety and tolerability investigation
IP Estate: Quantum BioPharma has rights to patent families licensed on an exclusive basis
Elite Team
Quantum BioPharma’s flagship subsidiary led by Dr. Lakshmi Kotra, the recipient of the Julia Levy Award and a senior scientist at the Krembil Brain Institute, as well as the world-renowned University Health Network (UHN).
Quantum BioPharma has a world class team working full-time on pipeline development, with backgrounds at the FDA, major pharmaceuticals firms, and esteemed universities.
Quantum BioPharma team includes Julia recipient, a distinguished award that has only been awarded to 8 recipients since its inception in 2005 (no other company can make this claim)
Strong Cash Position
Cash enough to carry operations
Solid Cap Table / Insider Ownership
Only 73,259,688 million shares issued
- 6 Class A shares
- 1,300,727 Class B shares
- 48,951 Options
- 138,077 Warrants
Share repurchase plan completed for 2022, approximately 2 million shares returned to treasury in 2022. Another 2 million shares returned to treasury in 2023.
Co-founders, directors and other insiders frequently buying shares since start of 2022 and continue to accumulate shares. This can be verified by checking the SEDI filings.
*Data current as of August 14, 2024
Industry Classifications
Sector
Healthcare
Industry
Drug Manufacturers
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical and Medicine Industry (3741)